{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:26:16Z","timestamp":1793348776936,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["806999"],"award-info":[{"award-number":["806999"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Functional decline in Alzheimer\u2019s disease (AD) is typically measured using single-time point subjective rating scales, which rely on direct observation or (caregiver) recall. Remote monitoring technologies (RMTs), such as smartphone applications, wearables, and home-based sensors, can change these periodic subjective assessments to more frequent, or even continuous, objective monitoring. The aim of the RADAR-AD study is to assess the accuracy and validity of RMTs in measuring functional decline in a real-world environment across preclinical-to-moderate stages of AD compared to standard clinical rating scales.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study includes three tiers. For the main study, we will include participants (<jats:italic>n<\/jats:italic>\u2009=\u2009220) with preclinical AD, prodromal AD, mild-to-moderate AD, and healthy controls, classified by MMSE and CDR score, from clinical sites equally distributed over 13 European countries. Participants will undergo extensive neuropsychological testing and physical examination. The RMT assessments, performed over an 8-week period, include walk tests, financial management tasks, an augmented reality game, two activity trackers, and two smartphone applications installed on the participants\u2019 phone. In the first sub-study, fixed sensors will be installed in the homes of a representative sub-sample of 40 participants. In the second sub-study, 10 participants will stay in a smart home for 1\u2009week.<\/jats:p>\n                <jats:p>The primary outcome of this study is the difference in functional domain profiles assessed using RMTs between the four study groups. The four participant groups will be compared for each RMT outcome measure separately. Each RMT outcome will be compared to a standard clinical test which measures the same functional or cognitive domain. Finally, multivariate prediction models will be developed. Data collection and privacy are important aspects of the project, which will be managed using the RADAR-base data platform running on specifically designed biomedical research computing infrastructure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>First results are expected to be disseminated in 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study is well placed to evaluate the clinical utility of RMT assessments. Leveraging modern-day technology may deliver new and improved methods for accurately monitoring functional decline in all stages of AD. It is greatly anticipated that these methods could lead to objective and real-life functional endpoints with increased sensitivity to pharmacological agent signal detection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00825-4","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T13:09:19Z","timestamp":1619183359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Remote monitoring technologies in Alzheimer\u2019s disease: design of the RADAR-AD study"],"prefix":"10.1186","volume":"13","author":[{"name":"the RADAR-AD Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-4602","authenticated-orcid":false,"given":"Marijn","family":"Muurling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Religa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Koychev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera J. M.","family":"Nies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Duyndam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meemansa","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Hannesdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Erdemli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lucivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanos G.","family":"Stravopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kompatsiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay V.","family":"Manyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav A.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"2","key":"825_CR1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741\u201366. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.741.","journal-title":"Physiol Rev"},{"issue":"4","key":"825_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Elliott C, Masliah E, Ryan L, Silverberg N. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"825_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamaneurol.2014.3375","volume":"72","author":"RE Amariglio","year":"2015","unstructured":"Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA, Alzheimer\u2019s Disease Cooperative Study. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer\u2019s Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol. 2015;72(4):446\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3375.","journal-title":"JAMA Neurol"},{"issue":"8","key":"825_CR4","doi-asserted-by":"publisher","first-page":"e12785","DOI":"10.2196\/12785","volume":"21","author":"A Piau","year":"2019","unstructured":"Piau A, Wild K, Mattek N, Kaye J. Current state of digital biomarker technologies for real-life, home-based monitoring of cognitive function for mild cognitive impairment to mild Alzheimer disease and implications for clinical care: systematic review. J Med Internet Res. 2019;21(8):e12785. https:\/\/doi.org\/10.2196\/12785.","journal-title":"J Med Internet Res"},{"key":"825_CR5","unstructured":"RADAR-AD. https:\/\/www.radar-ad.org\/. Accessed 9 June 2020."},{"key":"825_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1974","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u2018Mini-mental state\u2019 a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1974;12:189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"825_CR7","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134. https:\/\/doi.org\/10.1212\/WNL.43.11.2412-a.","journal-title":"Neurology."},{"issue":"1","key":"825_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.dadm.2017.03.002","volume":"8","author":"RJ Jutten","year":"2017","unstructured":"Jutten RJ, Peeters CF, Leijdesdorff SM, Visser PJ, Maier AB, Terwee CB, et al. Detecting functional decline from normal aging to dementia: development and validation of a short version of the Amsterdam IADL Questionnaire. Alzheimer\u2019s Dement. 2017;8(1):26\u201335. https:\/\/doi.org\/10.1016\/j.dadm.2017.03.002.","journal-title":"Alzheimer\u2019s Dement"},{"key":"825_CR9","unstructured":"RADAR-AD Patient Advisory Board. https:\/\/www.radar-ad.org\/patient-engagement\/patient-advisory-board. Accessed 9 June 2020."},{"key":"825_CR10","doi-asserted-by":"publisher","unstructured":"Owens AP, Hinds C, Manyakov NV, Stavropoulos TG, Lavelle G, Gove D, Diaz-Ponce A, Aarsland D. Selecting remote measurement technologies to optimize assessment of function in early Alzheimer\u2019s disease: a case study. Front Psychiatry. 2020;11 https:\/\/doi.org\/10.3389\/fpsyt.2020.582207.","DOI":"10.3389\/fpsyt.2020.582207"},{"issue":"2","key":"825_CR11","doi-asserted-by":"publisher","first-page":"e0169649","DOI":"10.1371\/journal.pone.0169649","volume":"12","author":"AR Doherty","year":"2017","unstructured":"Doherty AR, Jackson D, Hammerla N, Plotz T, Olivier P, Granat MH, et al. Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank Study. Plos One. 2017;12(2):e0169649. https:\/\/doi.org\/10.1371\/journal.pone.0169649.","journal-title":"Plos One"},{"key":"825_CR12","unstructured":"RADAR-base. https:\/\/radar-base.org\/. Accessed 9 June 2020."},{"issue":"8","key":"825_CR13","doi-asserted-by":"publisher","first-page":"e11734","DOI":"10.2196\/11734","volume":"7","author":"Y Ranjan","year":"2019","unstructured":"Ranjan Y, Rashid Z, Stewart C, Conde P, Begale M, Verbeeck D, Boettcher S, The Hyve, Dobson R, Folarin A, The RADAR-CNS Consortium. RADAR-base: open source mobile health platform for collecting, monitoring, and analyzing data using sensors, wearables, and mobile devices. JMIR mHealth and uHealth. 2019;7(8):e11734. https:\/\/doi.org\/10.2196\/11734.","journal-title":"JMIR mHealth and uHealth"},{"issue":"3","key":"825_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.amepre.2012.11.008","volume":"44","author":"AR Doherty","year":"2013","unstructured":"Doherty AR, Hodges SE, King AC, Smeaton AF, Berry E, Moulin CJ, et al. Wearable cameras in health: the state of the art and future possibilities. Am J Prev Med. 2013;44(3):320\u20133. https:\/\/doi.org\/10.1016\/j.amepre.2012.11.008.","journal-title":"Am J Prev Med"},{"issue":"3","key":"825_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.amepre.2012.11.006","volume":"44","author":"P Kelly","year":"2013","unstructured":"Kelly P, Marshall SJ, Badland H, Kerr J, Oliver M, Doherty AR, Foster C. An ethical framework for automated, wearable cameras in health behavior research. Am J Prev Med. 2013;44(3):314\u20139. https:\/\/doi.org\/10.1016\/j.amepre.2012.11.006.","journal-title":"Am J Prev Med"},{"key":"825_CR16","doi-asserted-by":"publisher","unstructured":"Lancaster C, Koychev I, Blane J, Chinner A, Wolters L, Hinds C. The Mezurio smartphone application: evaluating the feasibility of frequent digital cognitive assessment in the PREVENT dementia study. medRxiv. 2019:19005124. https:\/\/doi.org\/10.1101\/19005124.","DOI":"10.1101\/19005124"},{"key":"825_CR17","unstructured":"Gamechanger. https:\/\/www.alzheimers.org.uk\/research\/play-your-part\/gamechanger. Accessed 9 June 2020."},{"issue":"4","key":"825_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.dadm.2015.10.005","volume":"1","author":"I Tarnanas","year":"2015","unstructured":"Tarnanas I, Tsolaki A, Wiederhold M, Wiederhold B, Tsolaki M. Five-year biomarker progression variability for Alzheimer\u2019s disease dementia prediction: can a complex instrumental activities of daily living marker fill in the gaps? Alzheimers Dement (Amst). 2015;1(4):521\u201332. https:\/\/doi.org\/10.1016\/j.dadm.2015.10.005.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"825_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000346277","volume":"41","author":"SA Sikkes","year":"2013","unstructured":"Sikkes SA, Knol DL, Pijnenburg YA, de Lange-de Klerk ES, Uitdehaag BM, Scheltens P. Validation of the Amsterdam IADL Questionnaire(c), a new tool to measure instrumental activities of daily living in dementia. Neuroepidemiol. 2013;41(1):35\u201341.","journal-title":"Neuroepidemiol."},{"issue":"1","key":"825_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/s140100443","volume":"14","author":"F Dadashi","year":"2014","unstructured":"Dadashi F, Mariani B, Rochat S, B\u00fcla CJ, Santos-Eggimann B, Aminian K. Gait and foot clearance parameters obtained using shoe-worn inertial sensors in a large-population sample of older adults. Sensors. 2014;14(1):443\u201357.","journal-title":"Sensors."},{"key":"825_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pmcj.2016.06.006","volume":"34","author":"TG Stavropoulos","year":"2017","unstructured":"Stavropoulos TG, Meditskos G, Kompatsiaris I. DemaWare2: integrating sensors, multimedia and semantic analysis for the ambient care of dementia. Pervasive Mob Comput. 2017;34:126\u201345. https:\/\/doi.org\/10.1016\/j.pmcj.2016.06.006.","journal-title":"Pervasive Mob Comput"},{"key":"825_CR22","doi-asserted-by":"publisher","unstructured":"Arnal PJ, Thorey V, Ballard ME, Hernandez AB, Guillot A, Jourde H, et al. The Dreem headband as an alternative to polysomnography for EEG signal acquisition and sleep staging. BioRxiv. 2019;662734. https:\/\/doi.org\/10.1101\/662734.","DOI":"10.1101\/662734"},{"key":"825_CR23","unstructured":"ITI Smarthome. https:\/\/smarthome.iti.gr\/. Accessed 9 June 2020."},{"key":"825_CR24","unstructured":"ACTIVAGE. http:\/\/www.activageproject.eu\/. Accessed 9 June 2020."},{"key":"825_CR25","unstructured":"Dem@Care. http:\/\/www.demcare.eu\/. Accessed 9 June 2020."},{"issue":"2","key":"825_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"825_CR27","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Informatics. 2019;95:103208.","journal-title":"J Biomed Informatics"},{"issue":"1","key":"825_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07743-4","volume":"9","author":"AR Doherty","year":"2018","unstructured":"Doherty AR, Smith-Byrne K, Ferreira T, Holmes MV, Holmes C, Pulit SL, et al. GWAS identifies 14 loci for device-measured physical activity and sleep duration. Nat Commun. 2018;9(1):1\u20138.","journal-title":"Nat Commun"},{"key":"825_CR29","unstructured":"ADNI. http:\/\/adni.loni.usc.edu\/. Accessed 9 June 2020."},{"key":"825_CR30","unstructured":"AddNeuroMed. https:\/\/emif-catalogue.eu\/\/c\/adcohort. Accessed 9 June 2020."},{"issue":"7","key":"825_CR31","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.2196\/jmir.3465","volume":"16","author":"RA Stucki","year":"2014","unstructured":"Stucki RA, Urwyler P, Rampa L, Muri R, Mosimann UP, Nef T. A web-based non-intrusive ambient system to measure and classify activities of daily living. J Med Internet Res. 2014;16(7):e175. https:\/\/doi.org\/10.2196\/jmir.3465.","journal-title":"J Med Internet Res"},{"key":"825_CR32","first-page":"680","volume":"2014","author":"A Akl","year":"2014","unstructured":"Akl A, Snoek J, Mihailidis A. Generalized linear models of home activity for automatic detection of mild cognitive impairment in older adults. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:680\u20133.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"issue":"1","key":"825_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/JAD-130272","volume":"38","author":"T Kirste","year":"2014","unstructured":"Kirste T, Hoffmeyer A, Koldrack P, Bauer A, Schubert S, Schroder S, et al. Detecting the effect of Alzheimer\u2019s disease on everyday motion behavior. J Alzheimers Dis. 2014;38(1):121\u201332. https:\/\/doi.org\/10.3233\/JAD-130272.","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"825_CR34","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1212\/WNL.0b013e318259e1de","volume":"78","author":"H Dodge","year":"2012","unstructured":"Dodge H, Mattek N, Austin D, Hayes T, Kaye J. In-home walking speeds and variability trajectories associated with mild cognitive impairment. Neurology. 2012;78(24):1946\u201352. https:\/\/doi.org\/10.1212\/WNL.0b013e318259e1de.","journal-title":"Neurology."},{"key":"825_CR35","doi-asserted-by":"publisher","unstructured":"Dubbelman MA, Verrijp M, Facal D, S\u00e1nchez\u2010Benavides G, Brown LJ, van der Flier WM, Jokinen H, Lee A, Leroi I, Lojo\u2010Seoane C, Milo\u0161evi\u0107 V. The influence of diversity on the measurement of functional impairment: an international validation of the Amsterdam IADL Questionnaire in eight countries. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2020;12(1):e12021. https:\/\/doi.org\/10.1002\/dad2.12021.","DOI":"10.1002\/dad2.12021"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00825-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00825-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00825-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T13:24:57Z","timestamp":1619184297000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00825-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00825-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RK is an employee of Takeda Pharmaceuticals International Co. and holds stock options in both Pfizer Inc. and Takeda Pharmaceuticals International Co. IK receives consultancy fees from Mantrah Ltd. (mantrah.us), a digital technology company developing products for maintaining independence of people with cognitive impairment. CH is principal investigator on the Digital Biomarkers for Dementia project which is co-funded by Eli Lilly and Company and F. Hoffmann-La Roche Ltd. GE and KH are both currently employed by Novartis. NVM and VAN are employees of Janssen Pharmaceutica NV and may hold stock options or shares in the company. DA has received research support and\/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals, Biogen, and GE Health and served as a paid consultant for H. Lundbeck, Eisai, Heptares, and Mentis Cura.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}